Voya Investment Management LLC Lowers Holdings in Oscar Health, Inc. $OSCR

Key Points

• Voya Investment Management LLC reduced its holdings in Oscar Health, Inc. by 13.5% during the first quarter, leaving them with 178,007 shares valued at approximately $2.33 million.
• Several institutional investors significantly increased their positions in Oscar Health, including Jones Financial Companies Lllp with a 7,473.3% increase and Caitong International Asset Management Co. Ltd with a 484.6% increase during the same period.
• Oscar Health saw a recent downgrade from multiple brokerages, with UBS Group lowering its price target to $11.00, leading to an average consensus rating of "Strong Sell" and a price target of $12.07.

Voya Investment Management LLC lowered its stake in Oscar Health, Inc. (NYSE:OSCR - Free Report) by 13.5% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 178,007 shares of the company's stock after selling 27,868 shares during the quarter. Voya Investment Management LLC owned approximately 0.07% of Oscar Health worth $2,334,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently bought and sold shares of the company. Victory Capital Management Inc. boosted its stake in Oscar Health by 23.8% during the 1st quarter. Victory Capital Management Inc. now owns 285,997 shares of the company's stock valued at $3,749,000 after purchasing an additional 54,938 shares during the period. Toronto Dominion Bank acquired a new stake in shares of Oscar Health in the 4th quarter valued at $1,008,000. Concurrent Investment Advisors LLC acquired a new stake in shares of Oscar Health during the first quarter worth $677,000. Nuveen LLC acquired a new position in Oscar Health in the first quarter valued at about $29,684,000. Finally, NewEdge Advisors LLC grew its stake in Oscar Health by 89.7% in the first quarter. NewEdge Advisors LLC now owns 188,058 shares of the company's stock valued at $2,465,000 after acquiring an additional 88,946 shares during the period. 75.70% of the stock is owned by institutional investors and hedge funds.

Oscar Health Stock Performance

Shares of NYSE OSCR traded down $0.47 on Monday, reaching $18.50. 18,329,575 shares of the company's stock traded hands, compared to its average volume of 16,117,552. The business's 50 day simple moving average is $16.19 and its two-hundred day simple moving average is $15.26. Oscar Health, Inc. has a 12 month low of $11.20 and a 12 month high of $23.09. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.86 and a quick ratio of 0.86.

Oscar Health (NYSE:OSCR - Get Free Report) last announced its earnings results on Wednesday, August 6th. The company reported ($0.89) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.90) by $0.01. Oscar Health had a negative net margin of 1.50% and a negative return on equity of 13.78%. The company had revenue of $2.86 billion during the quarter, compared to analyst estimates of $2.88 billion. During the same period in the previous year, the business posted $0.20 earnings per share. The firm's quarterly revenue was up 29.0% compared to the same quarter last year. Equities analysts predict that Oscar Health, Inc. will post 0.69 EPS for the current year.

Wall Street Analysts Forecast Growth

OSCR has been the topic of several research analyst reports. Robert W. Baird restated a "neutral" rating and issued a $14.00 price objective (down previously from $28.00) on shares of Oscar Health in a research note on Friday, July 25th. Baird R W lowered Oscar Health from a "strong-buy" rating to a "hold" rating in a research report on Friday, July 25th. Barclays dropped their price target on Oscar Health from $17.00 to $11.00 and set an "underweight" rating on the stock in a research note on Wednesday, July 23rd. Wall Street Zen downgraded Oscar Health from a "hold" rating to a "sell" rating in a research note on Saturday, August 9th. Finally, Wells Fargo & Company downgraded Oscar Health from an "equal weight" rating to an "underweight" rating and cut their target price for the stock from $16.00 to $10.00 in a research note on Friday, July 11th. Four analysts have rated the stock with a Hold rating and five have given a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Strong Sell" and an average target price of $12.07.

Oscar Health Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.